-
-
-
-
-
-
-
Caris Life Sciences study identifies 13,293 patients for new cancer therapies
-
-
-
-
-
-
-
Goldman Sachs Starts Caris Life Sciences Inc (CAI) at Buy
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Hold Rating on Caris Life Sciences Inc (CAI)
-
-
-
-
-
-
-
Caris Life Sciences Inc (CAI) PT Raised to $37 at BofA Securities
-
-
-
-
-
-
-
Wolfe Research Starts Caris Life Sciences Inc (CAI) at Outperform
-
-
-
-
-
-
-
BofA Securities Starts Caris Life Sciences Inc (CAI) at Buy
-
-
-
-
-
-
455,630 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

